The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparison of chemoradiotherapy (CRT) using carboplatin/paclitaxel (CP) versus cisplatin/5-FU (CF) for esophageal or gastroesophageal junctional (GEJ) cancer.
 
Hao-Wen Sim
No Relationships to Disclose
 
Bryan Anthony Chan
No Relationships to Disclose
 
Akina Natori
No Relationships to Disclose
 
Charles Henry Lim
No Relationships to Disclose
 
Di Maria Jiang
No Relationships to Disclose
 
Stephanie Moignard
No Relationships to Disclose
 
Eric Xueyu Chen
Honoraria - Amgen; Lilly
 
Geoffrey Liu
Honoraria - novartis; pfizer
Consulting or Advisory Role - AstraZeneca/MedImmune; novartis; pfizer; Roche Canada; takeda
Research Funding - roche (Inst)
 
Gail Elizabeth Darling
No Relationships to Disclose
 
Carol Jane Swallow
No Relationships to Disclose
 
Savtaj Singh Brar
No Relationships to Disclose
 
James D. Brierley
No Relationships to Disclose
 
Jolie Ringash
No Relationships to Disclose
 
Rebecca Wong
No Relationships to Disclose
 
John Kim
No Relationships to Disclose
 
Patrik Rogalla
No Relationships to Disclose
 
Sara Hafezi-Bakhtiari
No Relationships to Disclose
 
Jennifer J. Knox
Honoraria - Novartis
Consulting or Advisory Role - Lilly; Merck
Research Funding - AstraZeneca
 
Raymond Woo-Jun Jang
Research Funding - AstraZeneca (Inst); Boston Biomedical (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst)
 
Elena Elimova
Employment - Merck (I)